Evidence map›Paper›PMID 27914629›Full record

ArticleBiological psychiatry2017

Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.

Stacey L Kirkpatrick, Lisa R Goldberg, Neema Yazdani, R Keith Babbs, Jiayi Wu, Eric R Reed, David F Jenkins, Amanda F Bolgioni, Kelsey I Landaverde, Kimberly P Luttik and 6 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. bioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Comparison of binge-eating disorder and food addiction.The Journal of international medical research · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Stacey L KirkpatrickLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts.
Lisa R GoldbergLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts.
Neema YazdaniLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts.
R Keith BabbsLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts.
Jiayi WuLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Ph.D. Program in Biomedical Sciences, Graduate Program in Genetics and Genomics, Boston University, Boston, Massachusetts; Transformative Training Program in Addiction Science, Boston University, Boston, Massachusetts.
Eric R ReedLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Ph.D. Program in Bioinformatics, Boston University, Boston, Massachusetts.
David F JenkinsComputational Biomedicine, Boston University, Boston, Massachusetts; Ph.D. Program in Bioinformatics, Boston University, Boston, Massachusetts.
Amanda F BolgioniLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts; Graduate Program in Biomolecular Pharmacology, Boston University, Boston, Massachusetts.
Kelsey I LandaverdeLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts.
Kimberly P LuttikLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts.
Karen S MitchellDepartment of Psychiatry, Boston University School of Medicine, Boston University, Boston, Massachusetts.
Vivek KumarThe Jackson Laboratory, Bar Harbor, Maine.
W Evan JohnsonComputational Biomedicine, Boston University, Boston, Massachusetts.
Megan K MulliganDepartment of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee.
Pietro CottoneLaboratory of Addictive Disorders, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts.
Camron D BryantLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Department of Psychiatry, Boston University, Boston, Massachusetts. Electronic address: camron@bu.edu.
Boston University · USJackson Laboratory · USUniversity of Tennessee Health Science Center · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Sequencing Mutant Mice With Altered Cocaine ResponsesU01DA041668 · NIDA · JACKSON LABORATORY · PI KUMAR, VIVEK · 2016 to 2020
$2.8M
Neurobiology of compulsive eating.R01DA030425 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COTTONE, PIETRO · 2011 to 2015
$1.6M
Genetic Basis of Opioid Reward and Aversion in MiceR00DA029635 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2013 to 2016
$750k
Genetic basis of binge eating and its motivational components in a reduced complexity crossR21DA038738 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2015 to 2016
$463k
Mapping G x E Interactions for Addiction Traits in a Reduced Complexity CrossR03DA038287 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2014 to 2015
$174k
Functional mechanisms of Hnrnph1 in methamphetamine addictive behaviorsF31DA040324 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI YAZDANI, NEEMA · 2016 to 2017
$49k
NIDA NIH HHS F31 DA040324NIDA NIH HHS R00 DA029635NIDA NIH HHS R01 DA030425NIDA NIH HHS R03 DA038287NIDA NIH HHS R21 DA038738NIDA NIH HHS U01 DA041668NIGMS NIH HHS T32 GM008541
6 · The paper itself

Abstract

backgroundEating disorders are lethal and heritable; however, the underlying genetic factors are unknown. Binge eating is a highly heritable trait associated with eating disorders that is comorbid with mood and substance use disorders. Therefore, understanding its genetic basis will inform therapeutic development that could improve several comorbid neuropsychiatric conditions.

methodsWe assessed binge eating in closely related C57BL/6 mouse substrains and in an F

resultsC57BL/6NJ but not C57BL/6J mice showed rapid and robust escalation in palatable food consumption. We mapped a single genome-wide significant quantitative trait locus on chromosome 11 (logarithm of the odds = 7.4) to a missense mutation in cytoplasmic FMR1-interacting protein 2 (Cyfip2). We validated Cyfip2 as a major genetic factor underlying binge eating in heterozygous knockout mice on a C57BL/6N background that showed reduced binge eating toward a wild-type C57BL/6J-like level. Transcriptome analysis of premorbid genetic risk identified the enrichment terms morphine addiction and retrograde endocannabinoid signaling, whereas binge eating resulted in the downregulation of a gene set enriched for decreased myelination, oligodendrocyte differentiation, and expression.

conclusionsWe identified Cyfip2 as a major significant genetic factor underlying binge eating and provide a behavioral paradigm for future genome-wide association studies in populations with increased genetic complexity.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBinge-Eating DisorderBulimiaCompulsive BehaviorCorpus StriatumFemaleMaleMice, Inbred C57BLMice, KnockoutMutation, MissenseNerve Tissue ProteinsQuantitative Trait LociTranscriptomeAdaptor Proteins, Signal TransducingCyfip2 protein, mouseNerve Tissue ProteinsAnxietyBingeEating disordersGWASMyelinPrader-Willi syndrome

Identifiers

PMID27914629
PMCPMC5386810
OpenAlexW2533849857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.